Skip to main content
SpringerLink
Log in

Synthesis, characterization and anticancer activity of 3-aza-analogues of DP-7

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

From the recent studies, 3,5-dibenzoyl-1,4-dihydropyridone (DHP) derivatives, DP-7, has emerged as a potent multidrug reverting agent that inhibits efflux of drug from cell wall by inhibiting the activity of ATP Binding Cassettes. On the other hand, dihydropyrimidine (DHPM) derivative, (aza analogue) namely, monastrol inhibits the protein Eg5, which is responsible for the separation of daughter chromosomes during cell division and controls the growth of the tumor cells. In the present report, we have reported the hybridize molecules of these two potent molecules to check the dual action in cancer chemotherapy by synthesizing various thio and oxo analogues, bearing substituted aryl groups at 4th position of the DHPM ring. The newly synthesized molecules were screened for antiproliferative effects in mdr1-gene transfected mouse lymphoma cell line (l5178 y). Among these newly synthesized compounds namely, II h, I g, I i, and I j showed a very potent antiproliferative activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Scheme 2

Similar content being viewed by others

References

  • Alderighi D, Sgaragli T, Dragoni S, Frosini M, Valoti M, Saponara S, Fusi F, Shah A, Kawasae M, Motohashi N, Molnar J, Sgaragli, G. 33rd National Conference of the Italian Society of Pharmacology, Cagliari, Italy, June 6–9, 2007

  • Alexander JS, Ardy VH, Gerrit VM, Katalin S, Ervin W, Gergely S, Andras V, Balazs S, Piet B (2000) MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J Biol Chem 275:23530–23539. doi:10.1074/jbc.M909002199

    Article  Google Scholar 

  • Biginelli P, Gazz P (1893) Synthesis of 3,4-dihydropyrimidin-2(1H)-ones. Chim Ital 23:360–413

    Google Scholar 

  • Borst P, Evers R, Kool M, Wijnholds J (2000) A family of drug transporters: the multidrug-resistance associated proteins. J Natl Cancer Inst 92:1295–1302. doi:10.1093/jnci/92.16.1295

    Article  PubMed  CAS  Google Scholar 

  • Brier S, Lemaire D, DeBonis S, Forest E, Kozielski F (2004) Identification of the protein binding region of S-trityl-l-cysteine, a new potent inhibitor of the mitotic kinesin Eg5. Biochemistry 43:13072–13082. doi:10.1021/bi049264e

    Article  PubMed  CAS  Google Scholar 

  • Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47:381–389. doi:10.1016/0092-8674(86)90595-7

    Article  PubMed  CAS  Google Scholar 

  • Cochran JC, Gatial JE, Kapoor TM, Gilbert SP (2005) Monastrol inhibition of the mitotic kinesin Eg5. J Biol Chem 280:12658–12667. doi:10.1074/jbc.M413140200

    Article  PubMed  CAS  Google Scholar 

  • Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650–1654. doi:10.1126/science.1360704

    Article  PubMed  CAS  Google Scholar 

  • Deeley RG, Cole SP (1997) Function, evolution and structure of multidrug-resistance protein (MRP). Semin Cancer Biol 8:193–204. doi:10.1006/scbi.1997.0070

    Article  PubMed  CAS  Google Scholar 

  • Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug-resistance. Annu Rev Biochem 58:137–171. doi:10.1146/annurev.bi.58.070189.001033

    Article  PubMed  CAS  Google Scholar 

  • Ferry DR, Malkandi PJ, Russell MA, Kerr DJ (1995) Allosteric regulation of [3H] vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine. Biochem Pharmacol 49:1851–1861. doi:10.1016/0006-2952(95)02078-0

    Article  PubMed  CAS  Google Scholar 

  • Furniss BS, Hannaford AJ, Smith PWG, Tatchell AR (1998) In Vogel’s text book of practical organic chemistry, 5th edn. Addison-Wesley Longman, Harlow, pp 634–635

    Google Scholar 

  • Fusi F, Saponara S, Valoti M, Dragoni SD, Ela P, Sgaragli T, Alderighi D, Kawase M, Shah A, Motohashi N, Sgaragli G (2006) Cancer cell permeability-glycoprotein as a target of MDR reverters: possible role of novel dihydropyridine derivatives. Curr Drug Targets 7:949–959

    Article  PubMed  CAS  Google Scholar 

  • Gottesman MM, Pastan I (1993) Biochemistry of multidrug-resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385–427. doi:10.1146/annurev.bi.62.070193.002125

    Article  PubMed  CAS  Google Scholar 

  • Gottesman MM, Fojo T, Bates SE (2002) Multidrug-resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48–58. doi:10.1038/nrc706

    Article  PubMed  CAS  Google Scholar 

  • Heald R (2000) Motor function in the mitotic spindle. Cell 102:399–402. doi:10.1016/S0092-8674(00)00044-1

    Article  PubMed  CAS  Google Scholar 

  • Higgins CF (1992) ABC transporters: from microorganisms to man. Annu Rev Cell Biol 8:67–113. doi:10.1146/annurev.cb.08.110192.000435

    Article  PubMed  CAS  Google Scholar 

  • Hofmann J, Wolf A, Spitaler M, Bock G, Drach J, Ludescher C, Grunicke HH (1992) Reversal of multidrug- resistance by B859–35, a metabolite of B859–35, niguldipine, verapamil and nitrendipine. J Cancer Res Clin Oncol 118:361–366. doi:10.1007/BF01294440

    Article  PubMed  CAS  Google Scholar 

  • Hollt V, Kouba M, Dietel M, Vogt G (1992) Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein. Biochem Pharmacol 43:2601–2608. doi:10.1016/0006-2952(92)90149-D

    Article  PubMed  CAS  Google Scholar 

  • Jauk B, Pernat T, Kappe CO (2000) Design and synthesis of a conformationally rigid mimic of the dihydropyrimidine calcium channel modulator SQ32, 926. Molecules 5:227–239

    Article  CAS  Google Scholar 

  • Juliano RL, Ling VA (1976) Surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152–162

    Article  PubMed  CAS  Google Scholar 

  • Kappe CO (1993) 100 Years of the Biginelli dihydropyrimidine synthesis. Tetrahedron 49:6937–6963. doi:10.1016/S0040-4020(01)87971-0

    Article  CAS  Google Scholar 

  • Kappe CO (1998) 4-Aryldihydropyrimidines via the Biginelli condensation: aza-analogs of nifedipine-type calcium channel nodulators. Molecules 3:1–9

    Article  CAS  Google Scholar 

  • Kappe CO (2000a) Recent advances in the Biginelli dihydropyrimidine synthesis. New tricks from an old dog. Acc Chem Res 33:879–888. doi:10.1021/ar000048h

    Article  PubMed  CAS  Google Scholar 

  • Kappe CO (2000b) Biologically active dihydripyrimidones of the Bignelli-type. A literature survey. Eur J Med Chem 35:1043–1052. doi:10.1016/S0223-5234(00)01189-2

    Article  PubMed  CAS  Google Scholar 

  • Kappe CO (2003) The generation of dihydropyrimidine libraries utilizing Biginelli multicomponent chemistry. QSAR Comb Sci 22:630–645

    Article  CAS  Google Scholar 

  • Kool M, Haas M, Scheffer GL, Scheper RJ, Vaneijk MJ, Juijn JA, Baas F, Borst P (1997) Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug-resistance associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57:3537–3547

    PubMed  CAS  Google Scholar 

  • Lecureur V, Courtois A, Payen L, Verhnet L, Guillouzo A, Fardel O (2000) Expression and regulation of hepatic drug and bile acid transporters. Toxicology 153:203–219. doi:10.1016/S0300-483X(00)00315-2

    Article  PubMed  CAS  Google Scholar 

  • Litman T, Druley TE, Stein WD, Bates SE (2001) From MDR to MXR: new understanding of multidrug- resistance systems, their properties and clinical significance. Cell Mol Life Sci 58:931–959

    Article  PubMed  CAS  Google Scholar 

  • Malkandi PJ, Ferry DR, Boer R, Gekeler V, Ise W, Kerr DJ (1994) Dexniguldipine-Hcl is a potent allosteric inhibitor of [3H] vinblastine binding to P-glycoprotein of CCRF ADR 500 cells. Eur J Pharmacol Mol Pharmacol 288:105–114

    Article  Google Scholar 

  • Mayer TU, Kapoor TM, Haggarty SJ, King RW, Schreiber SI, Mitchison TJ (1999) Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 268:971–974. doi:10.1126/science.286.5441.971

    Article  Google Scholar 

  • Molnar J, Gyemant N, Tanaka M, Hohmann J, Bergmann-Leitner E, Molnar P, Deli J, Diziapetris R, Ferreira MJU (2006) Inhibition of multidrug-resistance of cancer cells by natural diterpenes, triterpenes and carotenoids. Curr Pharm Design 12:287–311

    Article  CAS  Google Scholar 

  • Paulusma CC, Bosma PJ, Zaman GJR, Bakker CTM, Otter M, Scheffer GL, Scheper RJ, Borst P, Elferink RPJO (1996) Congenital jaundice in rats with a mutation in a multidrug-resistance associated protein gene. Science 271:1126–1128. doi:10.1126/science.271.5252.1126

    Article  PubMed  CAS  Google Scholar 

  • Paulusma CC, Kool M, Bosma PJ, Scheffer GL, Terborg F, Scheper RJ, Tytgat GNJ, Borst P, Baas F, OudeElferink RPJ (1997) A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin–Johnson syndrome. Hepatology 25:1539–1542. doi:10.1002/hep.510250635

    Article  PubMed  CAS  Google Scholar 

  • Peters T, Lindenmaier H, Haefeli WE, Weiss J (2006) Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein. Arch Pharmacol 372:291–299

    Article  CAS  Google Scholar 

  • Rampe D, Triggle DJ (1993) New synthetic ligands for L-type voltage-gated calcium channels. Prog Drug Res 40:191–238

    PubMed  CAS  Google Scholar 

  • Russowsky D, Canto RFS, Sanches SAA, Doca MGM, Fatima AN, Pilli RA, Kohn LK, Antonio MA, Carvalho JE (2006) Synthesis and differential antiproliferative activity of Bignelli compounds against cancer cell lines: monastrol, oxo monastrol and oxygenated analogues. Bioorg Chem 34:173–182. doi:10.1016/j.bioorg.2006.04.003

    Article  PubMed  CAS  Google Scholar 

  • Sakowicz R, Finer JT, Beraud C, Crompton A, Lewis E, Fritsch A, Lee Y, Mak J, Moody R, Turincio R, Chabal JC, Gonzales P, Roth S, Weitman S, Wood KW (2004) Potentiation of Antitumor activity of a kinesin inhibitor. Cancer Res 64:3276–3280. doi:10.1158/0008-5472

    Article  PubMed  CAS  Google Scholar 

  • Saponara S, Ferrara A, Gorelli B, Shah A, Kawase M, Motohashi N, Molnar J, Sgaragli G, Fusi F (2007) 3,5-dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7): a new multidrug-resistance inhibitor devoid of effects on Langendorff-perfused rat heart. Eur J Pharmacol 563:160–163. doi:10.1016/j.ejphar.2007.02.001

    Article  PubMed  CAS  Google Scholar 

  • Szabo D, Molnar J (2006) The role of stereoselectivity of chemosensitizers in the reversal of multidrug- resistance of mouse lymphoma cells. Anticancer Res 18:3039–3044

    Google Scholar 

  • Triggle DJ (2003) Drug targets in the voltage-gated calcium channel family: why some are and some are not. Assay Drug Dev Technol 1:719–733. doi:10.1089/154065803770381075

    Article  PubMed  CAS  Google Scholar 

  • Tsuruo T, Iida H, Tsukagoshi S, Sakura Y (1983) Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blocker. Cancer Res 43:2267–2272

    PubMed  CAS  Google Scholar 

  • Ueda K, Cardarelli C, Gottesman MM, Pastan I (1987) Expression of a full-length cDNA for the human “MDR1” gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci 84:3004–3008

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Ferozepur Road, Moga, 142 001, India

    Jalpa J. Bariwal, Manav Malhotra & Jitender B. Bariwal

  2. Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Szeged, Hungary

    Joseph Molnar

  3. Sinhgad College of Pharmacy, Vadgaon (Bk.), Pune, 411 0041, India

    Kishor S. Jain

  4. Department of Chemistry, Saurashtra University, Rajkot, 360 005, India

    Jalpa J. Bariwal, Anamik K. Shah & Jitender B. Bariwal

  5. Department of Medicinal Chemistry, ISF College of Pharmacy, Ferozepur G.T. Road, Moga, 142 001, Punjab, India

    Jitender B. Bariwal

Authors
  1. Jalpa J. Bariwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manav Malhotra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joseph Molnar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kishor S. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anamik K. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jitender B. Bariwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jitender B. Bariwal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bariwal, J.J., Malhotra, M., Molnar, J. et al. Synthesis, characterization and anticancer activity of 3-aza-analogues of DP-7. Med Chem Res 21, 4002–4009 (2012). https://doi.org/10.1007/s00044-011-9925-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-011-9925-5

Keywords

Search

Navigation